1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 用途別スニペット
3.3. エンドユーザー別スニペット
3.4. 流通チャネル別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加
4.1.2. 阻害要因
4.1.2.1. 体液管理モニタリングシステムシステムの高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. 償還分析
5.6. 特許分析
5.7. SWOT分析
5.8. DMI意見
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. 流体管理ソフトウェア
6.2.1. 導入
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. 体液管理デバイス
7. 用途別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
7.1.2. 市場魅力度指数：用途別
7.2. 外科手術
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 心臓血管外科
7.4. 整形外科
7.5. 脳神経外科
7.6. 一般外科
7.7. 泌尿器外科
7.8. クリティカルケア
7.9. 小児医療
7.10. 新生児ケア
7.11. 創傷管理
8. エンドユーザー別
8.1. はじめに
8.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院*市場
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 外来手術センター
8.4. 専門クリニック
8.5. 在宅医療プロバイダー
9. 流通チャネル別
9.1. はじめに
9.1.1. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
9.1.2. 市場魅力度指数（流通チャネル別
9.2. 直接販売
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 医療用品の販売業者
9.4. オンライン販売
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 地域別主要市場
10.2.2.1. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.2.2.2. 市場規模分析および前年比成長率分析（%）：用途別
10.2.2.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.2.2.4. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
10.2.3. 市場規模分析および前年比成長率分析（%）, 国別
10.2.3.1. 米国
10.2.3.2. カナダ
10.2.3.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 地域別主要市場
10.3.2.1. 市場規模分析および前年比成長率分析(%)、製品タイプ別
10.3.2.2. 市場規模分析および前年比成長率分析（%）：用途別
10.3.2.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.3.2.4. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
10.3.3. 市場規模分析および前年比成長率分析（%）, 国別
10.3.3.1. ドイツ
10.3.3.2. イギリス
10.3.3.3. フランス
10.3.3.4. イタリア
10.3.3.5. スペイン
10.3.3.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.2.1. 市場規模分析および前年比成長率分析(%)、製品タイプ別
10.4.2.2. 市場規模分析および前年比成長率分析（%）：用途別
10.4.2.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.4.2.4. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
10.4.3. 市場規模分析および前年比成長率分析（%）, 国別
10.4.3.1. ブラジル
10.4.3.2. アルゼンチン
10.4.3.3. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.2.1. 市場規模分析および前年比成長率分析(%)、製品タイプ別
10.5.2.2. 市場規模分析および前年比成長率分析（%）：用途別
10.5.2.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.5.2.4. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
10.5.3. 市場規模分析および前年比成長率分析（%）, 国別
10.5.3.1. 中国
10.5.3.2. インド
10.5.3.3. 日本
10.5.3.4. 韓国
10.5.3.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 地域別主要市場
10.6.2.1. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
10.6.2.2. 市場規模分析および前年比成長率分析（%）：用途別
10.6.2.3. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10.6.2.4. 市場規模分析および前年比成長率分析（%）, 流通チャネル別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. Baxter International Inc. *
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Fresenius Medical Care AG & Co. KGaA
12.3. Cardinal Health, Inc.
12.4. Stryker Corporation
12.5. B. Braun Melsungen AG
12.6. Medtronic plc
12.7. Olympus Corporation
12.8. Smith’s Medical
12.9. Ecolab Inc.
12.10. KARL STORZ GmbH & Co. KG
リストは網羅的ではありません
13. 付録
13.1. 会社概要とサービス
13.2. お問い合わせ
The global fluid management monitoring market reached US$ 1.96 billion in 2023 and is expected to reach US$ 3.43 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031.
The process of fluid management is one of the most complicated areas in medicine, especially in an inpatient setting that emphasizes the individual needs of each patient. In many instances, especially in patients that are confined to bed, the reliability of the control of hydration is impaired, with resultant high morbidity and even mortality. Fluid management, therefore, is very important because it satisfies the physiological needs, including fluids that are lost.
Market Dynamics: Drivers & Restraints
Rise in the Prevalence of Chronic Diseases
The worldwide marketplace for fluid management monitoring systems is seeing tremendous growth owing to the rising cases of chronic diseases, such as kidney disease, heart failure, diabetes, and others. Such diseases require careful and exact monitoring in order to avoid complications and ensure positive results. With such investments, healthcare providers are purchasing high-end systems that provide accurate data in real-time for timely and better end results.
As the prevalence of chronic diseases increases on the global stage with the growing aging population and lifestyle trends, the need for dependable solutions for fluid management control is projected to increase hence making these systems supportive in dealing with the care complexity of most patients.
For instance, according to Mayo Clinic 2023, the transition between infectious and noncommunicable diseases began in the early 1900s due to improved public health. As individuals live longer, chronic disease prevalence and cost continue to rise, with the estimated cost reaching $47 trillion by 2030. Individual lifestyle, behaviors, and community factors significantly influence the development and management of chronic diseases.
High costs of Fluid Management Monitoring System systems
The global fluid management monitoring systems market is not spared from the stiff competition, mostly due to the high costs involved especially in developing regions where hospitals deal with resource and budget constraints. This financial limit prevents a large-scale implementation of these advanced equipment, even when they are needed for effective management of patients with fluid problems. Also, in low resource environments, the cost of maintenance, training, and software upgrades, etc. limits the access of this technology.
For instance, HysteroLux Fluid Management System Control Unit costs around U$ 4000-10,000 like this other company products cost varies high which hinders the overall market to grow during the forecast period.
Segment Analysis
The global fluid management monitoring system market is segmented based on product type, , application, end user, distribution channel and region.
Fluid management devices segment is expected to dominate the market share
The fluid management devices segment are expected to hold a significant portion of the market share. In healthcare environments such as the operating theatre, the emergency department, and the intensive care unit, fluid management devices play an important role in controlling and measuring patient’s fluid saturation levels. They allow for the monitoring of the data in real-time thereby minimizing the chances of over hydration or dehydration of a patient.
The development of technology incorporated solid state devices to allow collection, analysis of data, and easy interaction with EHR’S (Electronic Health Records) enhancing clarity of medical decisions and increasing the recovery chances in patients. Rising occurrences of chronic illnesses, geriatric populace, and less invasive surgical procedures are stimulating the uptake of these devices, making them essential devices in the system for fluid management monitoring market.
For instance, in August 2024, Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitect, a flexible, single-use solution for biopharmaceutical fluid management. The platform builds on previous products like puresu and asepticsu, aiming to streamline processes, protect products, and reduce regulatory burden.
Geographical Analysis
North America is expected to hold a significant position in the fluid management monitoring system market share
North America is expected to hold a significant position in the global Fluid Management Monitoring System market during the forecast period due to the rapid growth in the geriatric population, the rise in chronic diseases, FDA clearance, the increase in research and development, an increase in technology and many more. Higher living standards and the rise in the number of people suffering from cancer has brought about an increase in demand for fluid administration systems, disposable accessories and also for minimally invasive surgeries.
For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.
Moreover, in August 2022, Zynex, a medical technology company, has started enrolling in an ongoing apheresis clinical trial using its second-generation fluid monitoring system, the CM-1600. The study uses the CM-1500 and CM-1600 devices during an apheresis procedure to refine the system's patented Relative Index.
Market Segmentation
By Product Type
• Fluid Management Software
• Fluid Management Devices
By Application
• Surgical Procedures
• Cardiovascular Surgery
• Orthopedic Surgery
• Neurosurgery
• General Surgery
• Urology Surgery
• Critical Care
• Pediatric Care
• Neonatal Care
• Wound Management
By End-User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Home Healthcare Providers
By Distribution Channel
• Direct Sales
• Medical Supply Distributors
• Online Sales
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cardinal Health, Inc., Stryker Corporation,B. Braun Melsungen AG, Medtronic plc, Olympus Corporation, Smiths Medical, Ecolab Inc, KARL STORZ GmbH & Co. KG among others.
Key Developments
• In July 2024, Boston Scientific Corporation is considering the sale of its fluid management business, formerly North American Medical Instruments Corp., as part of its ongoing asset review. The business, which produces products for managing fluid and measuring pressure during angiography and angioplasty procedures, is expected to include the company's facilities in Glens Falls, New York and Tullamore, Ireland.
Why Purchase the Report?
• To visualize the global fluid management monitoring system
Market Segmentation based on product type, application, end user, distribution channel, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of fluid management monitoring system market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global fluid management monitoring system market report would provide approximately 70 tables, 69 figures, and 202 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Distribution Channel
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the Prevalence of Chronic Diseases
4.1.2. Restraints
4.1.2.1. High Costs of Fluid Management Monitoring System Systems
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Fluid Management Software*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Fluid Management Devices
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Surgical Procedures*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiovascular Surgery
7.4. Orthopedic Surgery
7.5. Neurosurgery
7.6. General Surgery
7.7. Urology Surgery
7.8. Critical Care
7.9. Pediatric Care
7.10. Neonatal Care
7.11. Wound Management
8. By End User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Specialty Clinics
8.5. Home Healthcare Providers
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Direct Sales*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Supply Distributors
9.4. Online Sales
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.3.1. The U.S.
10.2.3.2. Canada
10.2.3.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.3.1. Germany
10.3.3.2. UK
10.3.3.3. France
10.3.3.4. Italy
10.3.3.5. Spain
10.3.3.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.3.1. Brazil
10.4.3.2. Argentina
10.4.3.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.3.1. China
10.5.3.2. India
10.5.3.3. Japan
10.5.3.4. South Korea
10.5.3.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.6.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Baxter International Inc. *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Fresenius Medical Care AG & Co. KGaA
12.3. Cardinal Health, Inc.
12.4. Stryker Corporation
12.5. B. Braun Melsungen AG
12.6. Medtronic plc
12.7. Olympus Corporation
12.8. Smith’s Medical
12.9. Ecolab Inc.
12.10. KARL STORZ GmbH & Co. KG
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us
*** 体液管理モニタリングシステムの世界市場に関するよくある質問(FAQ) ***
・体液管理モニタリングシステムの世界市場規模は？
→DataM Intelligence社は2023年の体液管理モニタリングシステムの世界市場規模を19億6,000万米ドルと推定しています。
・体液管理モニタリングシステムの世界市場予測は？
→DataM Intelligence社は2031年の体液管理モニタリングシステムの世界市場規模を34億3,000万米ドルと予測しています。
・体液管理モニタリングシステム市場の成長率は？
→DataM Intelligence社は体液管理モニタリングシステムの世界市場が2024年～2031年に年平均6.5%成長すると展望しています。
・世界の体液管理モニタリングシステム市場における主要プレイヤーは？
→「Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cardinal Health, Inc., Stryker Corporation,B. Braun Melsungen AG, Medtronic plc, Olympus Corporation, Smiths Medical, Ecolab Inc, KARL STORZ GmbH & Co. KGなど ...」を体液管理モニタリングシステム市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
